Immunohematology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Immunohematology market size was valued at USD 1.8 billion in 2017 and is expected to witness a 5% CAGR from 2021 to 2027.

Immunohmatology is a field of medicine that focuses on the study of red blood cell (RBC) antibodies and antigens associated with blood transfusions and blood banks. Various immunohematologic tests involve processing blood samples for more than 230 antigens present in RBCs, which fall into two broad categories: polypeptides and carbohydrates.

Immunohematology Market Key Segments

By Product

  • Analyzers & Systems
  • Reagents

By Application

  • Blood-related diseases
  • HIV
  • Hepatitis

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks

Key Players

Some key industry participants include Bio-Rad Laboratories, Inc.; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic, Inc.; Siemens Healthcare GmbH; ThermoFisher; Abbott; and Beckman Coulter, Inc.

Scope of the Report

The research study analyzes the global Immunohematology industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Immunohematology Market Report

1. What was the Immunohematology Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Immunohematology Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Immunohematology Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation